2:03 PM
Feb 15, 2019
 |  BC Extra  |  Politics & Policy

NICE provides first scientific advice on patient preference

The National Institute for Health and Care Excellence said on Thursday that it provided its first scientific advice to Novartis AG (NYSE:NVS; SIX:NOVN) on the design of a patient preference study for chronic obstructive pulmonary disease (COPD).

Preference studies aim...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >